SPDR S&P Biotech ETF

AMEX: XBI · Real-Time Price · USD
82.64
0.54 (0.66%)
At close: Jun 18, 2025, 3:59 PM
82.30
-0.41%
After-hours: Jun 18, 2025, 07:57 PM EDT
0.66%
Bid 81.5
Market Cap 4.57B
AUM 4.68B
NAV 82.1
EPS (ttm) n/a
PE Ratio (ttm) n/a
Shares Out 55.35M
Inception Date Jan 30, 2006
Ask 82.87
Volume 8.67M
Open 82.27
Previous Close 82.10
Day's Range 81.53 - 83.42
52-Week Range 66.66 - 105.47
Holdings 127
Expense Ratio 0.35%

About XBI

The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select IndustryTM Index (the “Index”)Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

Asset Class Equity
Ticker Symbol XBI
Inception Date Jan 30, 2006
Provider State Street
Exchange AMEX

Top Sectors

Sector Weight %
Healthcare 100.00%
All Sectors

Top 10 Holdings 27.76% of assets

Name Symbol Weight
Insmed Incorporated INSM 3.35%
Alnylam Pharmaceutic... ALNY 3.19%
Blueprint Medicines ... BPMC 2.95%
Exact Sciences Corpo... EXAS 2.90%
Natera, Inc. NTRA 2.87%
Neurocrine Bioscienc... NBIX 2.86%
Incyte Corporation INCY 2.51%
Gilead Sciences, Inc... GILD 2.42%
Amgen Inc. AMGN 2.37%
Biogen Inc. BIIB 2.34%
View More Holdings

Dividends Dividend Yield 0.03%

Ex-Dividend Amount Payment Date
Mar 24, 2025 $0.0053 Mar 26, 2025
Dec 23, 2024 $0.0027 Dec 26, 2024
Sep 23, 2024 $0.0152 Sep 25, 2024
Jun 24, 2024 $0.1148 Jun 26, 2024
Dec 18, 2023 $0.0139 Dec 21, 2023
Full Dividend History
1 month ago
-6.63%
Shares of vaccine and gene therapy stocks are trad... Unlock content with Pro Subscription